MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-HR-18-0001800
Combitic Global Caplet Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹154.55 Cr
▲ 37% YoY
Net profit · FY 2025
₹12.88 Cr
Net margin 8.3%
EBITDA · FY 2025
₹52.31 Cr
EBITDA margin 33.8%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹4.02 Cr
Issued & subscribed
Open charges
₹79.85 Cr
Satisfied ₹77.55 Cr
Company age
45 yrs
Est. 1981
Employees · EPFO
318
Provident fund records
About Combitic Global Caplet Private Limited
Data last updated:
Combitic Global Caplet Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 December 1981 and has been in existence for over 45 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL1981PTC012922. Its GSTIN is 06AAACU4144N2Z5 (Haryana). The company holds 4 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.02 Cr. It was formerly known as Unisule Private Limited and Uni-Sule Private Limited. It is led by directors Dinesh Kaushik and Shashank Garg.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 17 New Rohtak Road Karol Bagh, New Delhi, Delhi, India – 110005.
As per the financials filed for FY 2025, the company reported a revenue of ₹154.55 Cr, a growth of 37% compared to the previous year. For the same year it recorded a net profit of ₹12.88 Cr (net margin 8.3%) and EBITDA of ₹52.31 Cr (EBITDA margin 33.8%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 4% over five years.
The company has about 318 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Combitic Global Caplet. As per MCA filings, the company has open charges of ₹79.85 Cr and satisfied charges of ₹77.55 Cr on record. Court records list 236 cases involving the company, including 183 filed by the company and 55 filed against it; 41 cases are pending. The company has 8 deals on record (4 secondary share transfers, 3 funding rounds, 1 debt financing), with disclosed funding of ₹77.89 Cr; the latest was in April 2019. Its 9 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 4 smaller; the largest is VHB Medi Sciences Limited with revenue of ₹159.28 Cr. The company has 5 MSME Form 1 returns on record between 2019 and 2021, listing 29 overdue payments to 25 micro and small suppliers.
Combitic Global Caplet Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-18-0001800). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cgcaplet.com.
Company Details of Combitic Global Caplet Private Limited
CIN U74999DL1981PTC012922
Registration Number 012922
Incorporation Date 30 December 1981
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-HR-18-0001800
Name History
Combitic Global Caplet has undergone 2 name changes throughout its history. The company was previously known as Unisule Private Limited, and Uni-Sule Private Limited. The current legal name is Combitic Global Caplet Private Limited.
| Company Name | Status |
|---|---|
| Combitic Global Caplet Private Limited | Current |
| Unisule Private Limited | Previous |
| Uni-Sule Private Limited | Previous |
CIN History
Combitic Global Caplet has one previous CIN (Corporate Identification Number): U74899DL1981PTC012922. The current CIN is U74999DL1981PTC012922, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74999DL1981PTC012922 | Current |
| U74899DL1981PTC012922 | Previous |
Key People
Dinesh Kaushik Director Shashank Garg Director Recognitions & Rankings of Combitic Global Caplet
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address17 New Rohtak Road Karol Bagh, New Delhi, Delhi, India – 110005
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Combitic Global Caplet Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands
Combitic Global Caplet operates one associated brand: Combitic Global Caplet. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Exporting and manufacturing pharmaceutical products in India. | combiticglobalcaplet.com |
Business Activity
The main business activity of Combitic Global Caplet is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Financials of Combitic Global Caplet Private Limited
FY 2025 filings availableCombitic Global Caplet Private Limited reported revenue of ₹154.55 Cr (up 37% YoY) for FY 2025.
Revenue · FY 2025
₹154.55 Cr ▲ 37%
Net profit · FY 2025
₹12.88 Cr margin 8.3%
EBITDA · FY 2025
₹52.31 Cr margin 33.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 37%
3 years · compounded
▼ 18%
5 years · compounded
▲ 4%
EBITDA CAGR growth
1 year
▲ 220%
3 years · compounded
▲ 8%
5 years · compounded
▲ 18%
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 37% growth in the latest year. EBITDA rose 220% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | |
| Other Income | •••• | |
| Total Revenue | ₹154.55 Cr | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | ₹52.31 Cr | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | ₹12.88 Cr | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2024-25 | FY 2020-21 to FY 2023-24in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 33.8% | |
| Net Profit Margin | 8.3% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2020-21 to FY 2023-24, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Combitic Global Caplet are in the company report.
: available in the company report
Board of Directors of Combitic Global Caplet Private Limited
Combitic Global Caplet has 2 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dinesh Kaushik | Director | 24 Oct 2025 | 0 Years 11 Months | Current |
| Shashank Garg | Director | 30 Sep 2022 | 4 Years 0 Months | Current |
Peer Comparison
Combitic Global Caplet Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| VHB Medi Sciences Limited | ₹159.28 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Kandivlai West, Maharashtra, India |
| Jenburkt Pharmaceuticals Ltd Listed | ₹158.41 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Mumbai, Maharashtra, India |
| Wardex Pharmaceuticals Private Limited | ₹158.1 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Chennai, Tamil Nadu, India |
| Nitin Lifesciences Limited | ₹157.19 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Paonta Sahib, Himachal Pradesh, India |
| Wings Pharmaceuticals Pvt Ltd | ₹155.72 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | New Delhi, Delhi, India |
| Combitic Global Caplet Private Limited this company | ₹154.55 Cr (FY 2025) | •••• | •••• | 37.0% | •••• | New Delhi, Delhi, India |
| Medico Remedies Limited Listed | ₹153.63 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Mumbai, Maharashtra, India |
| Sanzyme Private Limited | ₹153.25 Cr (FY 2025) | •••• | •••• | -27.0% | •••• | Hyderabad, Telangana, India |
| D K Pharma Chem Private Limited | ₹153.13 Cr (FY 2024) | •••• | •••• | -33.0% | •••• | Badlapur, Maharashtra, India |
| Hema Laboratories Pvt Ltd | ₹152.89 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Wadhwancity, Gujarat, India |
Peers are the companies nearest to Combitic Global Caplet by revenue, above and below it, in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details
Combitic Global Caplet Private Limited is audited by A.RAHUL & CO. for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| A.RAHUL & CO. | Locked | Locked | Locked |
: available in the company report
Ownership and Shareholding
: available in the company report
Charges & Borrowings
Open charges
₹79.85 Cr
Satisfied charges
₹77.55 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Dec 2024 | Others | ₹28.5 Cr | Open |
| 13 Feb 2024 | Others | ₹28.5 Cr | Open |
| 07 Oct 2020 | Others | ₹22.85 Cr | Open |
| 24 Feb 2020 | Axis Bank Limited | ₹99.04 Lakh | Satisfied |
| 20 May 2019 | Others | ₹6.3 Cr | Satisfied |
Total charge records: 9 View all charges
Deals & Funding
Combitic Global Caplet Private Limited has 8 deals on record (4 secondary share transfers, 3 funding rounds, 1 debt financing), with disclosed funding of ₹77.89 Cr; the latest was in April 2019.
Total deals
8
Secondary share transfers
4
Funding rounds
3
Debt financing
1
Disclosed funding
₹77.89 Cr
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Apr 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Hare Krishna Exotic Private Limited |
| Mar 2018 | Debt financing | ₹15 Cr | Investors: Rajeev Goel HUF, 3 individuals |
| May 2010 | Secondary share transfer | Undisclosed | Buyer: Hare Krishna Exotic Private Limited Seller: Priya Tissue Private Limited , an individual |
| Jun 2009 | Funding round | ₹17.78 Cr | Investors: Priya Tissue Private Limited , 2 individuals |
: available in the company report
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases
Combitic Global Caplet Private Limited has 236 court cases on record: 183 filed by Combitic Global Caplet, 55 filed against it. 41 cases are pending and 195 are disposed.
Total cases
236
Filed by the company
183
Filed against the company
55
Pending
41
Disposed
195
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 152 | 33 | 27 |
| High courts | 78 | 20 | 13 |
| Supreme Court | 6 | 2 | 1 |
Cases on record (5 of 236)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Sonepat, Haryana | Cheque dishonour complaint | Filed by the company against M/S Prasannabiomolecules Pvt. Ltd. and 2 others | Pending |
| High Court, MAHARASHTRA | Court case (COMMP) | Filed by the company against Hab Pharmaceuticals and Research Ltd. and Another and 1 other | Pending |
| High Court of Delhi | Writ petition | Filed by the company against The Pharmaceuticals Export Promotion Council of India | Pending |
| High Court of Punjab and Haryana | Court case (RERA-APPL) | Filed against the company by Ilc Infracon Pvt Ltd | Disposed |
| High Court of Delhi | Court case (O.M.P.(I) (COMM.)) | Filed by the company against M/S Ambika Realcon Builders Pvt Ltd | Disposed |
: available in the company report
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays
Combitic Global Caplet Private Limited has 5 MSME Form 1 returns on record between 2019 and 2021, listing 29 overdue payments to 25 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 25)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| Para Products Private Limited | •••• | •••• | •••• |
| S P Cargo Agency Private Limited | •••• | •••• | •••• |
| Batchmaster Software Private Limited | •••• | •••• | •••• |
| Joy Pack (India) Private Limited | •••• | •••• | •••• |
: available in the company report
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance
Combitic Global Caplet Private Limited has a workforce of 318 employees as of Mar 29, 2025.
Employee count
318
Active EPFO establishments
1
Employee growth
-6.47%
: available in the company report
Recent Activity
Combitic Global Caplet Private Limited has 14 board changes on record since 2009: 2 appointments and 12 cessations. The latest: Dinesh Kaushik was appointed as Director on 24 Oct 2025.
Appointed
Dinesh Kaushik was appointed as Director.
Charges
A charge registered on 16 Oct 2017 via Charge ID 100133786 with Others was fully satisfied on 13 Oct 2025.
Filing
Combitic Global Caplet Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Others amounted to Rs. 28.50 Cr with Charge ID 101023936 was registered on 20 Dec 2024.
AGM
Combitic Global Caplet Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Ceased
Sushila Rani ceased to be Director.
Ceased
Shivank Garg ceased to be Director.
Charges
A charge with Others amounted to Rs. 28.50 Cr with Charge ID 100876048 was registered on 13 Feb 2024.
Ceased
Ram Chander Verma ceased to be Additional Director.
Appointed
Shashank Garg was appointed as Director.
Charges
A charge with Others of Rs. 22.85 Cr registered on 07 Oct 2020 with Charge ID 100382645 was modified on 26 Nov 2021.
Charges
A charge registered on 24 Feb 2020 via Charge ID 100353235 with Axis Bank Limited was fully satisfied on 04 Jul 2021.
21 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
Combitic Global Caplet has 4 GST registrations: 1 active and 3 cancelled or inactive.
Total GSTINs
4
Active
1
Cancelled / inactive
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAACU4144N2Z5 | Haryana | Active | 01 Jul 2017 |
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
Combitic Global Caplet is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 December 1981 (45+ years old) and is registered under CIN U74999DL1981PTC012922.
Combitic Global Caplet has 2 current directors:
- Dinesh Kaushik - Director
- Shashank Garg - Director
The latest financial statements of Combitic Global Caplet on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Combitic Global Caplet is 06AAACU4144N2Z5, registered in Haryana. The company has 4 GST registrations in all, of which 1 is active and 3 are cancelled or inactive.
The CIN (Corporate Identification Number) of Combitic Global Caplet is U74999DL1981PTC012922. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Combitic Global Caplet has 236 court cases on record: 183 filed by the company and 55 filed against it. 41 are pending. Most are in the district courts.
Combitic Global Caplet was incorporated on 30 December 1981, making it 45+ years old. It is registered with the Registrar of Companies, Delhi.
Combitic Global Caplet has 8 deals on record (4 secondary share transfers, 3 funding rounds, 1 debt financing), with disclosed funding of ₹77.89 Cr; the latest was in April 2019.
The peers of Combitic Global Caplet by revenue are VHB Medi Sciences Limited, Jenburkt Pharmaceuticals Ltd, Wardex Pharmaceuticals Private Limited, Nitin Lifesciences Limited, Wings Pharmaceuticals Pvt Ltd and 4 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Dinesh Kaushik was appointed as Director on 24 Oct 2025. Sushila Rani ceased to be Director on 06 Jun 2024. Shivank Garg ceased to be Director on 08 Mar 2024. Combitic Global Caplet has 14 board changes on record in total.
Yes, Combitic Global Caplet is registered as a medium enterprise under Udyam registration (number: UDYAM-HR-18-0001800).
Combitic Global Caplet has 5 MSME Form 1 returns on record between 2019 and 2021, listing 29 overdue payments to 25 micro and small suppliers. The latest return was filed on 27 Oct 2021.